Know a great AI tool or AI news source? Submit it to AiByts
fda2 min read

FDA Warns GLP-1s May Increase Risk of Sudden Blindness

An anonymous reader quotes a report from NBC News: The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.

By BeauHDSlashdot
FDA Warns GLP-1s May Increase Risk of Sudden Blindness

Read the full story

Originally published by Slashdot on Nov 10, 2026.

Read on Slashdot(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.